A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia

NCT01350947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelomonocytic Leukemia

Interventions

DRUG: 5-Azacitidine

Sponsor

University of Utah

Collaborators

[object Object]